Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding

R. J. Chen, J. F. Fang, M. F. Chen

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

We report two clinical experiences in the treatment of postoperative enterocutaneous fistula and stress ulcer bleeding with octreotide acetate (Sandostatin). In both patients, upper gastrointestinal bleeding occurred 7 days after operation, and the bleeding proved to be stress ulceration, by panendoscopic examination. Enterocutaneous fistulas also were found in both patients. One was high output (750 ml/day), and the other was low output (50 ml/day). Octreotide 50-100 μg was given subcutaneously every 8 h. After three doses of octreotide, a significant reduction in fistula output and control of the stress ulcer bleeding were noted. The fistulas closed promptly after nine doses of octreotide, but the first patient's fistula recurred 2 days later, with fluid losses of about 100-200 ml/day. This fistula closed spontaneously 1 month after discharge. Octreotide appears to be useful as an adjunct to the conventional treatment of enterocutaneous fistulas, especially those complicated by stress ulcer bleeding.

Original languageEnglish
Pages (from-to)1212-1215
Number of pages4
JournalAmerican Journal of Gastroenterology
Volume87
Issue number9
Publication statusPublished - 1992
Externally publishedYes

Fingerprint

Intestinal Fistula
Octreotide
Ulcer
Hemorrhage
Fistula
Therapeutics

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding. / Chen, R. J.; Fang, J. F.; Chen, M. F.

In: American Journal of Gastroenterology, Vol. 87, No. 9, 1992, p. 1212-1215.

Research output: Contribution to journalArticle

@article{76316ff1bed444c39f87bf3706d07a64,
title = "Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding",
abstract = "We report two clinical experiences in the treatment of postoperative enterocutaneous fistula and stress ulcer bleeding with octreotide acetate (Sandostatin). In both patients, upper gastrointestinal bleeding occurred 7 days after operation, and the bleeding proved to be stress ulceration, by panendoscopic examination. Enterocutaneous fistulas also were found in both patients. One was high output (750 ml/day), and the other was low output (50 ml/day). Octreotide 50-100 μg was given subcutaneously every 8 h. After three doses of octreotide, a significant reduction in fistula output and control of the stress ulcer bleeding were noted. The fistulas closed promptly after nine doses of octreotide, but the first patient's fistula recurred 2 days later, with fluid losses of about 100-200 ml/day. This fistula closed spontaneously 1 month after discharge. Octreotide appears to be useful as an adjunct to the conventional treatment of enterocutaneous fistulas, especially those complicated by stress ulcer bleeding.",
author = "Chen, {R. J.} and Fang, {J. F.} and Chen, {M. F.}",
year = "1992",
language = "English",
volume = "87",
pages = "1212--1215",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Octreotide in the management of postoperative enterocutaneous fistulas and stress ulcer bleeding

AU - Chen, R. J.

AU - Fang, J. F.

AU - Chen, M. F.

PY - 1992

Y1 - 1992

N2 - We report two clinical experiences in the treatment of postoperative enterocutaneous fistula and stress ulcer bleeding with octreotide acetate (Sandostatin). In both patients, upper gastrointestinal bleeding occurred 7 days after operation, and the bleeding proved to be stress ulceration, by panendoscopic examination. Enterocutaneous fistulas also were found in both patients. One was high output (750 ml/day), and the other was low output (50 ml/day). Octreotide 50-100 μg was given subcutaneously every 8 h. After three doses of octreotide, a significant reduction in fistula output and control of the stress ulcer bleeding were noted. The fistulas closed promptly after nine doses of octreotide, but the first patient's fistula recurred 2 days later, with fluid losses of about 100-200 ml/day. This fistula closed spontaneously 1 month after discharge. Octreotide appears to be useful as an adjunct to the conventional treatment of enterocutaneous fistulas, especially those complicated by stress ulcer bleeding.

AB - We report two clinical experiences in the treatment of postoperative enterocutaneous fistula and stress ulcer bleeding with octreotide acetate (Sandostatin). In both patients, upper gastrointestinal bleeding occurred 7 days after operation, and the bleeding proved to be stress ulceration, by panendoscopic examination. Enterocutaneous fistulas also were found in both patients. One was high output (750 ml/day), and the other was low output (50 ml/day). Octreotide 50-100 μg was given subcutaneously every 8 h. After three doses of octreotide, a significant reduction in fistula output and control of the stress ulcer bleeding were noted. The fistulas closed promptly after nine doses of octreotide, but the first patient's fistula recurred 2 days later, with fluid losses of about 100-200 ml/day. This fistula closed spontaneously 1 month after discharge. Octreotide appears to be useful as an adjunct to the conventional treatment of enterocutaneous fistulas, especially those complicated by stress ulcer bleeding.

UR - http://www.scopus.com/inward/record.url?scp=0026700289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026700289&partnerID=8YFLogxK

M3 - Article

C2 - 1519586

AN - SCOPUS:0026700289

VL - 87

SP - 1212

EP - 1215

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 9

ER -